학술논문
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Document Type
Article
Author
Source
In: Breast Cancer Research . (Breast Cancer Research, 1 December 2020, 22(1))
Subject
Language
English
ISSN
1465542X
14655411
14655411